Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru.

Q3 Medicine Revista Peruana de Medicina de Experimental y Salud Publica Pub Date : 2023-04-01 DOI:10.17843/rpmesp.2023.402.12409

Giancarlo Alvarado-Gamarra, Vanessa Zarate-Campos, Jimena A Saavedra Díaz, Renato M Sánchez Julca, Andrea Tahua Vega, Aida Borcic, Alvaro Taype-Rondan, Luis Miguel Franchi Prato, Claudio F Lanata, Jesús Dominguez-Rojas, Raquel Garcés-Ghilardi, Matilde Estupiñan-Vigil

{"title":"Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru.","authors":"Giancarlo Alvarado-Gamarra, Vanessa Zarate-Campos, Jimena A Saavedra Díaz, Renato M Sánchez Julca, Andrea Tahua Vega, Aida Borcic, Alvaro Taype-Rondan, Luis Miguel Franchi Prato, Claudio F Lanata, Jesús Dominguez-Rojas, Raquel Garcés-Ghilardi, Matilde Estupiñan-Vigil","doi":"10.17843/rpmesp.2023.402.12409","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives.: </strong>Motivation for the study. There are few reports on the clinical experience of the population infected with the omicron variant of COVID-19 in Latin America, particularly in pediatric population. Main findings. There was a rapid increase in the number of hospitalizations compared to previous waves, mainly due to respiratory conditions; most patients progressed favorably. Antibiotics and corticosteroids were the most used drugs. Implications. Studying the characteristics of children hospitalized during the third wave of COVID-19 in Peru may increase the knowledge of how the omicron variant affects this population group, which will allow comparisons with possible new waves or diseases.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":" ","pages":"200-206"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953665/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Peruana de Medicina de Experimental y Salud Publica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17843/rpmesp.2023.402.12409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives.: Motivation for the study. There are few reports on the clinical experience of the population infected with the omicron variant of COVID-19 in Latin America, particularly in pediatric population. Main findings. There was a rapid increase in the number of hospitalizations compared to previous waves, mainly due to respiratory conditions; most patients progressed favorably. Antibiotics and corticosteroids were the most used drugs. Implications. Studying the characteristics of children hospitalized during the third wave of COVID-19 in Peru may increase the knowledge of how the omicron variant affects this population group, which will allow comparisons with possible new waves or diseases.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

秘鲁一家转诊医院第三波(欧姆变异)期间因COVID-19住院的儿科患者的特征

这项研究的目的是描述在Edgardo Rebagliati Martins国家医院（HNERM）（秘鲁利马）第三波（omicron变体）期间住院的新型冠状病毒19儿科患者（28天至14岁）的特征。在这一回顾性队列中，回顾了2022年1月至4月初在HNREM接受治疗的122名儿科患者的临床病史（55%为男性，中位年龄为5岁），第一个月为77.9%，其中一半有一些合并症。他们主要因呼吸困难、失代偿综合征和脱水住院。6.6%的人接受了重症监护，4.9%的人接受了有创机械通气，5.7%的人需要一些血管活性物质，1.6%的人死亡。使用最多的药物是抗生素（43.4%）和皮质类固醇（27.1%）。总之，与前几波相比，住院人数迅速增加，其中大多数都有良好的发展，并且大量使用抗生素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Revista Peruana de Medicina de Experimental y Salud Publica Medicine-Public Health, Environmental and Occupational Health

CiteScore

3.00

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： La Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) es el órgano oficial de difusión científica del Instituto Nacional de Salud (INS) del Perú. Es una publicación arbitrada por pares, de periodicidad trimestral, de ámbito y difusión mundial, indizada en MEDLINE/Index Medicos, SCOPUS, EMBASE, SciELO Salud Pública y otras bases de datos internacionales. La RPMESP es distribuida en su versión impresa y electrónica, con acceso gratuito a texto completo. La RPMESP publica artículos referidos a temas del ámbito biomédico y de salud pública, resaltando aportes prácticos, que contribuyan a mejorar la situación de salud del país y de la región. Propicia el intercambio de la experiencia científica en salud entre instituciones y personas dedicadas a la investigación dentro y fuera del Perú a fin de promover el avance y la aplicación de la investigación en salud.